Regeneron Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.03.21	EMA Safety Committee To Further Review AZD1222, RUBY Sparkles, DMD Trial Data Fails To Ignite SLDB (RTTNews)
15.03.21	Sanofi : Phase 3 Trial Of Libtayo In Advanced Cervical Cancer Stopped Early For Positive Result (RTTNews)
04.03.21	Sanofi : FDA Accepts Dupixent For Review In Children With Moderate-to-severe Asthma (RTTNews)
26.02.21	Roche : CHMP Opinion Supports Use Of Casirivimab-imdevimab Antibody Cocktail For COVID Treatment (RTTNews)
25.02.21	Regeneron Pharma Stops Placebo Group Enrollment For REGEN-COV On Advice From IDMC (RTTNews)
11.02.21	US Federal Court Upholds Appeal In Favor Of Regeneron, Sanofi On Praluent (RTTNews)
11.02.21	BPTH On Steady Path, CGIX On Watch, GLPG/GILD Scrap IPF Drug, REGN's Libtayo Gets FDA Nod (RTTNews)
05.02.21	Regeneron Pharmaceuticals Q4 adjusted earnings Beat Estimates (RTTNews)
27.01.21	Regeneron: Researchers Confirm Ability Of REGEN-COV To Neutralize SARS-CoV-2 Variants (RTTNews)
27.01.21	AGIO's ACTIVATE-T Hits Goals, EDSA Catches Eye, JNJ Provides Rosy Outlook, VXRT On Watch (RTTNews)
26.01.21	Regeneron's Interim Late-stage Study Shows Antibody Cocktail Effective To Prevent COVID-19 (RTTNews)
13.01.21	Roche : US To Purchase Addl Doses Of Antibody Cocktail For Use In Non-hospitalised COVID-19 Patients (RTTNews)
30.12.20	Big Winners In 2020! Could These Stocks Outperform Again In 2021? (RTTNews)
30.12.20	Regeneron Says Initial Data From COVID-19 Antibody Cocktail Trial Encouraging (RTTNews)
02.12.20	OVID Plunges, VNDA's Hetlioz Scores Another FDA Nod, Auris Investors Smile Ear To Ear (RTTNews)
30.11.20	Regeneron Reports Approval Of Dupixent In Europe For Children With Severe Atopic Dermatitis (RTTNews)
23.11.20	Pre-market Movers In Healthcare Sector: EIGR, SNOA, REGN, TTNP, OCGN… (RTTNews)
23.11.20	FDA Grants Emergency Use Approval To Regeneron's COVID-19 Antibody Therapy (RTTNews)
16.11.20	New Drugs Approved In October (RTTNews)
05.11.20	Regeneron Pharmaceuticals Q3 adjusted earnings Beat Estimates (RTTNews)
03.11.20	AUPH's Dry Eye Syndrome Study Fails, KPTI's SEAL Study Hits Goal, REGN Halts Rare Bone Disease Trial (RTTNews)
30.10.20	Regeneron : IDMC Recommends To Hold Enrollment In Hospitalized High Risk COVID-19 Patients (RTTNews)
29.10.20	European Patent Office Rules In Favor Of Sanofi, Regeneron On Praluent (RTTNews)
29.10.20	Regeneron Says Its Covid-19 Outpatient Therapy Could Reduce Virus Levels (RTTNews)
26.10.20	Biotech Stocks Facing FDA Decision In November 2020 (RTTNews)
15.10.20	FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade (RTTNews)
15.10.20	FDA Approves Regeneron's Inmazeb To Treat Ebola (RTTNews)
14.10.20	LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS (RTTNews)
13.10.20	Regeneron: Phase 3 Trial Shows Dupixent Significantly Reduces Severe Asthma Attacks In Children (RTTNews)
08.10.20	Regeneron Seeks Emergency Use Authorization For Its Antibody Treatment For Covid-19 (RTTNews)
08.10.20	Pre-market Movers In Healthcare Sector: CDNA, IMTX, REGN, CRSP, TLC... (RTTNews)
05.10.20	Stock Alert: Regeneron Pharmaceuticals Gains 6% (RTTNews)
04.10.20	Trump Says 'real Test' Ahead In His COVID-19 Fight (RTTNews)
30.09.20	Regeneron Says Antibody Cocktail REGN-COV2 Reduced Symptoms In COVID-19 Patients (RTTNews)
26.09.20	Biotech Stocks Facing FDA Decision In October 2020 (RTTNews)
14.09.20	Regeneron's Antibody Cocktail To Be Tested In RECOVERY COVID-19 Phase 3 Trial In UK (RTTNews)
14.09.20	Regeneron And Sanofi: Dupixent Granted FDA Breakthrough Therapy Designation For EoE (RTTNews)
08.09.20	Regeneron/Sanofi Reveal Promising Long-term Data Of Dupixent In Moderate-to-severe Asthma (RTTNews)
19.08.20	Regeneron, Roche Collaborate To Manufacture And Distribute Investigational Drug For COVID-19 (RTTNews)
05.08.20	Regeneron Pharmaceuticals Q2 adjusted earnings Beat Estimates (RTTNews)
08.07.20	CRVS, HEPA Jump On COVID-19 Drug Bandwagon, LVGO In Good Health, NVAX Joins $100 Stock Price Club (RTTNews)
07.07.20	Regeneron Enters Manufacturing And Supply Deal With BARDA For REGN-COV2 (RTTNews)
07.07.20	BLU Plunges On RELIEF Data, FDA Places CLLS' Trial On Hold, IMMU Hits New High, OTIC Music To Ears (RTTNews)
06.07.20	Regeneron Begins Late-stage Clinical Trials Evaluating REGN-COV2 - Quick Facts (RTTNews)
03.07.20	Sanofi, Regeneron Stop Kevzara COVID-19 Trial In U.S. After Failing To Meet Key Goals (RTTNews)
03.07.20	IMMU Continues Ascent, IDXG On Fire, REGN's Kevzara Disappoints In COVID-19 Trial, BLFS On Watch (RTTNews)
24.06.20	Regeneron To Defend Allegations On Contributions To Patient Assistance Charity (RTTNews)
19.06.20	Regeneron : China Okays Dupixent To Treat Moderate-to-Severe Atopic Dermatitis In Adults (RTTNews)
11.06.20	Regeneron Begins Clinical Trial Of Anti-Viral Antibody Cocktail Against COVID-19 (RTTNews)
11.06.20	Regeneron's (REGN) Resplendent Journey From $60 To $600 In 9 Years (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

19.11.24		Zuversicht in New York: NASDAQ 100 mit positivem Vorzeichen
31.10.24		NASDAQ-Handel NASDAQ 100 schlussendlich in Rot
31.10.24		NASDAQ Composite-Handel aktuell: NASDAQ Composite am Donnerstagnachmittag in der Verlustzone
31.10.24		NASDAQ 100-Handel aktuell: Das macht der NASDAQ 100 aktuell
31.10.24		Zurückhaltung in New York: So performt der NASDAQ 100 aktuell
31.10.24		Angespannte Stimmung in New York: NASDAQ Composite liegt mittags im Minus
31.10.24		Zurückhaltung in New York: NASDAQ 100 zum Handelsstart im Minus
31.10.24		Donnerstagshandel in New York: NASDAQ Composite verliert zum Handelsstart

19.11.24

Zuversicht in New York: NASDAQ 100 mit positivem Vorzeichen

31.10.24

NASDAQ-Handel NASDAQ 100 schlussendlich in Rot

31.10.24

NASDAQ Composite-Handel aktuell: NASDAQ Composite am Donnerstagnachmittag in der Verlustzone

31.10.24

NASDAQ 100-Handel aktuell: Das macht der NASDAQ 100 aktuell

31.10.24

Zurückhaltung in New York: So performt der NASDAQ 100 aktuell

31.10.24

Angespannte Stimmung in New York: NASDAQ Composite liegt mittags im Minus